Description
Buy Acomplia (Generic) 20 mg Online(rimonabant) was the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1).
Acomplia was studied for use in the treatment of obesity and related conditions.http://www.kyivpharmaceuticals.com
Diet pill Acomplia is a miraculous multifunctional pill that helps you short out obesity as well as smoking. Acomplia diet pills work on the Endocannabinoid system, which controls appetite and energy expenditure (as well as the urge to smoke). This wonder pill selectively blocks some receptors in the Endocannabinoid system, thus creating a better balance which in turn suppresses appetite and the longing to overeat.
How Taken
20 mg tablet once daily in the morning before breakfast
Missed Dose
If you miss a daily dose take another dosage the following day, if you are late taking your dosage you can take it before your next meal.
How does Acomplia work?
• Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle1.
• Acomplia switches off the same brain circuits that make people hungry when they smoke cannabis.
• CB1 receptor blockade with Acomplia acts to decrease the overactivity of the endocannabinoid system (EC system)2,3. The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.
buy acomplia
acomplia side effects
acomplia reviews
buy rimonabant online cheap
rimonabant india
rimonabant uses
rimonabant fda
rimonabant dosage
• Sanofi argues that Acomplia can also prevent the risk of cardiovascular disease.
• Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the drug.
Buy Acomplia (Generic) 20 mg Online
Reviews
There are no reviews yet.